艾司氯胺酮的多巴胺能效应由谷氨酸与阿片受体双重机制介导
研究在小鼠中评估艾司氯胺酮对运动、焦虑和操作反应的影响,并用在体纤维光度法探测伏隔核神经化学效应。艾司氯胺酮通过损害多巴胺清除而非促进释放来增加细胞外多巴胺张力,同时降低谷氨酸能活动;其多巴胺能效应可被纳洛酮部分且条件性阻断,并需要谷氨酸能输入。
要点
- 艾司氯胺酮增加小鼠运动并升高细胞外多巴胺张力,机制为损害多巴胺清除而非促进释放。
- 艾司氯胺酮降低多巴胺自发释放事件频率并损害奖赏诱发多巴胺释放,减少操作反应率。
- 上述多巴胺能效应可被阿片拮抗剂纳洛酮部分且条件性阻断,并需要谷氨酸能输入。
核心结论
- 艾司氯胺酮的神经化学效应是回路依赖和状态依赖的,涉及神经递质系统间的复杂交互。
研究设计与样本
- 在小鼠中评估艾司氯胺酮对运动、焦虑测试和操作反应的影响,并用在体纤维光度法探测伏隔核神经化学效应。
主要发现
- 在自由活动小鼠中,艾司氯胺酮增加运动并升高细胞外多巴胺张力,机制为损害多巴胺清除而非促进多巴胺释放,同时降低谷氨酸能活动。
- 艾司氯胺酮降低多巴胺自发释放事件频率并损害奖赏诱发多巴胺释放,导致操作反应率下降。
- 这些多巴胺能效应被阿片拮抗剂纳洛酮部分且条件性阻断,并需要谷氨酸能输入。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Esketamine represents a new class of drugs for treating mood disorders. Unlike traditional monoaminergic-based therapies, esketamine primarily targets N-methyl-D-aspartate receptors (NMDAR). However, esketamine is a complex drug with low affinity for NMDAR and can also bind to other targets, such as opioid receptors. Its precise mechanism of action for its antidepressant properties remains debated, as does its potential for misuse. A key component at the intersection of mood and reward processing is the dopaminergic system. In this study, we evaluated the effects of esketamine in locomotion, anxiety tests and operant responding and we used in vivo fiber photometry to explore the neurochemical effects of esketamine in the nucleus accumbens of mice. Our findings demonstrated multifaceted effects of esketamine on neurotransmitter dynamics. In freely behaving mice, esketamine increased locomotion and increased extracellular dopamine tone -by impairing dopamine clearance rather than promoting dopamine release- while decreasing glutamatergic activity. However, it decreased dopamine spontaneous release event frequency and impaired reward-evoked dopamine release, leading to a reduction in operant responding rates. These dopaminergic effects were partially, and conditionally, blocked by the opioid antagonist naloxone and required glutamatergic input. In summary, our study reveals a complex interaction between neurotransmitter systems, suggesting that the neurochemical effects of esketamine are both circuit- and state-dependent.
引用
- Rizzo A, Garçon-Poca MZ, Essmann A, et al. The dopaminergic effects of esketamine are mediated by a dual mechanism involving glutamate and opioid receptors. Mol Psychiatry. 2025. PMID: 39972056. doi:10.1038/s41380-025-02931-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。